Belite Bio, Inc
BLTE
$155.54
$3.572.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 12/31/2024 | 12/31/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -150.73% | -- | -- | -- | -- |
| Total Depreciation and Amortization | 0.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 327.26% | -- | -- | -- | -- |
| Change in Net Operating Assets | -47.87% | -- | -- | -- | -- |
| Cash from Operations | -125.71% | -- | -- | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,066.89% | -- | -- | -- | -- |
| Cash from Investing | -1,067.58% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 239.59% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 61,421.37% | -- | -- | -- | -- |
| Cash from Financing | 1,182.51% | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | 63.54% | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,105.31% | -- | -- | -- | -- |